Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat.

J Clin Med Res · 2019 · PMC6681854 · PMID 31413774

Europe PMC DOI

hedged sentences

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

There was a trend toward a lower serum creatinine level in the treatment group compared with controls after 12 months of therapy, although it did not reach statistical significance (P = 0.08).

also in 111,027 other papers

showed a trendno p-value reported

eGFR did not change 3 months after, however, eGFR showed a trend to increase 6 months after.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.